It also shows the resulting concentration, total doses per vial, and cost per dose if you input the vial price
Those under consideration next month include BPC-157, TB-500 and MOTs-C, among others that have grown popular among influencers and some clinicians
Browse stacks
The benefits tend to plateau after about six months, and increased dosages may lead to more side effects [1]
As clinicians (even non-prescribing clinicians), I think we need: - Curiosity - An understanding of how it might impact our rehab program design Better evidence, not anecdotes (the studies are mostly animal based) Conversations, not blank stares Because whether we like it or not, this isnt fringe anymore
BPC-157 and TB-500: Typically 23 times per week via subcutaneous injection CJC-1295 + Ipamorelin: Often daily or every other day, depending on your protocol Dosages vary widely based on your situation